均瑶健康
(605388)
| 流通市值：37.35亿 | | | 总市值：37.35亿 |
| 流通股本：6.00亿 | | | 总股本：6.00亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 137,617,933.18 | 244,841,096.47 | 211,165,263.42 | 146,286,587.28 |
| 应收票据及应收账款 | 114,189,295.38 | 90,309,360.47 | 154,226,184.3 | 138,265,258.95 |
| 应收账款 | 114,189,295.38 | 90,309,360.47 | 154,226,184.3 | 138,265,258.95 |
| 预付款项 | 144,003,468.31 | 137,598,360.23 | 114,317,790.1 | 111,327,716.3 |
| 其他应收款合计 | 115,185,023.61 | 123,815,964.68 | 156,087,312.15 | 153,791,864.09 |
| 其中:应收利息 | - | - | - | 29,581.93 |
| 存货 | 256,670,514.37 | 279,593,294.91 | 184,964,562.78 | 184,361,000.49 |
| 其他流动资产 | 38,785,804 | 49,860,453.36 | 31,222,443.15 | 40,262,894.16 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 958,327,705.52 | 1,080,864,363.47 | 983,642,708.14 | 978,487,139.26 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 21,500,000 | 21,500,000 | 21,500,000 | 21,500,000 |
| 投资性房地产 | 48,231,317.08 | 48,925,066.87 | 49,618,816.66 | 50,312,566.45 |
| 固定资产 | 750,946,691.56 | 764,710,798.82 | 766,400,447.66 | 729,272,821.05 |
| 在建工程 | 49,349,681.51 | 48,749,064.41 | 48,795,220.8 | 92,730,461.96 |
| 使用权资产 | 12,232,700.56 | 13,813,376.29 | 14,517,011.13 | 6,157,844.18 |
| 无形资产 | 145,012,612.05 | 148,392,145.2 | 151,346,830.96 | 148,981,191.19 |
| 商誉 | 142,497,163.88 | 142,497,163.88 | 178,929,725.27 | 178,929,725.27 |
| 长期待摊费用 | 3,808,742.53 | 3,849,947.85 | 4,238,618.85 | 4,258,013.88 |
| 递延所得税资产 | 35,265,562.35 | 34,765,327.71 | 22,719,477.63 | 23,340,649.48 |
| 其他非流动资产 | 6,051,573.87 | 5,431,088.6 | 31,440,106.09 | 33,346,928.58 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,214,896,045.39 | 1,232,633,979.63 | 1,289,506,255.05 | 1,288,830,202.04 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,173,223,750.91 | 2,313,498,343.1 | 2,273,148,963.19 | 2,267,317,341.3 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 191,410,766.94 | 225,022,955.8 | 181,092,002.51 | 185,709,907.75 |
| 其中：应付票据 | 20,526,515.43 | 25,898,521.99 | 28,595,538.17 | 36,462,535 |
| 应付账款 | 170,884,251.51 | 199,124,433.81 | 152,496,464.34 | 149,247,372.75 |
| 合同负债 | 76,344,699.34 | 160,445,928.55 | 53,226,398.79 | 67,727,263.87 |
| 应付职工薪酬 | 19,729,546.42 | 29,788,495.55 | 22,758,942.53 | 19,714,373.67 |
| 应交税费 | 11,796,766.98 | 9,351,875.7 | 13,113,541.3 | 4,562,164.43 |
| 其他应付款合计 | 33,016,779.33 | 36,968,076.46 | 38,223,225.78 | 40,852,279.68 |
| 应付股利 | 1,039,500 | 1,039,500 | 1,039,500 | 1,039,500 |
| 一年内到期的非流动负债 | 8,971,326.3 | 9,918,291.92 | 8,623,733.48 | 5,447,126.72 |
| 其他流动负债 | 9,573,836.43 | 20,593,708.23 | 6,722,657.51 | 8,668,868.28 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 350,843,721.74 | 492,089,332.21 | 323,760,501.9 | 332,681,984.4 |
| 非流动负债: | | | | |
| 租赁负债 | 7,120,627.96 | 7,695,529.16 | 9,694,594.83 | 1,381,758 |
| 长期应付款 | 14,916,042.96 | 14,726,304.97 | 14,538,564.89 | 6,292,615.63 |
| 预计负债 | 892,888.48 | 1,491,934.85 | 1,488,554.72 | 924,378.84 |
| 递延收益 | 11,141,468.72 | 9,234,624.32 | 9,427,779.92 | 19,385,352.05 |
| 递延所得税负债 | 21,932,383.54 | 23,479,021.08 | 24,929,501.62 | 22,726,802.95 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 56,003,411.66 | 56,627,414.38 | 60,078,995.98 | 50,710,907.47 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 406,847,133.4 | 548,716,746.59 | 383,839,497.88 | 383,392,891.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 600,484,000 | 600,484,000 | 600,484,000 | 600,484,000 |
| 资本公积 | 697,364,637.9 | 697,365,806.58 | 697,379,231.82 | 697,381,127.29 |
| 减:库存股 | 100,002,745.86 | 91,976,455.86 | 47,938,249.06 | 41,550,274.26 |
| 盈余公积 | 115,937,931.13 | 115,937,931.13 | 113,728,110.15 | 113,728,110.15 |
| 未分配利润 | 462,007,427.35 | 451,100,322.77 | 531,847,527.84 | 517,189,232.95 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,775,791,250.52 | 1,772,911,604.62 | 1,895,500,620.75 | 1,887,232,196.13 |
| 少数股东权益 | -9,414,633.01 | -8,130,008.11 | -6,191,155.44 | -3,307,746.7 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,766,376,617.51 | 1,764,781,596.51 | 1,889,309,465.31 | 1,883,924,449.43 |
| 负债和股东权益合计 | 2,173,223,750.91 | 2,313,498,343.1 | 2,273,148,963.19 | 2,267,317,341.3 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-30 | 2024-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |